Physician profile
Omar Mostafa
NPI 1295397909
$3,140.22
in general payments reported to CMS, 2019-2025
10 companies · $891 in 2025
The $891 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $165 · 2024: $2,084 · 2025: $891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947 · Travel and Lodging: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,947.25 |
| Travel and Lodging | $1,192.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,010.09 | 2023-2025 | Wavewriter Alpha Prime 16, Infinion 16, Intracept |
| Abbott Laboratories | $229.13 | 2024-2025 | Eterna, Proclaim |
| Saluda Medical Americas, INC. | $211.66 | 2025 | Evoke |
| Medtronic, INC. | $195.88 | 2025 | Inceptiv |
| Nevro Corp. | $140.30 | 2024 | Senza |
| Averitas Pharma INC. | $123.13 | 2023-2025 | Qutenza |
| Curonix LLC | $114.37 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $57.60 | 2025 | Mild Device Kit |
| Vertos Medical, INC. | $39.45 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $18.61 | 2025 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Mostafa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.